Given thatFAM129B silencing inhibits Wnt/β-catenin target gene expression and apoptotic response to WNT3A, we sought to determine ifFAM129B expression levels predict Wnt/β-catenin pathway activation in patient melanoma samples. The gene discussed is WNT3A; the disease is melanoma.